
Rapport Therapeutics Inc
RAPPNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$39.06
Day High
$39.69
Day Low
$38.14
Prev. Close
$39.49
VolumeShares traded today.
263.44K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$1.89B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-15.18
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$42.27
52W LowLowest price over the past 52 weeks.
$8.20
50D MAAverage closing price over the last 50 trading days.
$34.82
200D MAAverage closing price over the last 200 trading days.
$28.40
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+7.6%1M
+19.7%6M
+38.2%YTD
+40.5%1Y
+377.6%About
Steven M. Paul is an American neuroscientist, psychiatrist, and biopharmaceutical executive. As of 2025, Paul is the co-founder and board chair of Rapport Therapeutics and Seaport Therapeutics. He is the former CEO and board chair of Karuna Therapeutics. Paul is a Venture Partner at Third Rock Ventures. Paul is also a professor of psychiatry and neurology at Washington University School of Medicine in St. Louis.
www.rapportrx.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade RAPP
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.